VAXCYTE, INC. Other Commitment, to be Paid, Remainder of Fiscal Year
VAXCYTE, INC. (PCVX) had Other Commitment, to be Paid, Remainder of Fiscal Year of $394.16 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Other Commitments
us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2026-08-05
- 2026-06-30: Other Commitment, to be Paid, Remainder of Fiscal Year $394.16M.
- 2026-03-31: Other Commitment, to be Paid, Remainder of Fiscal Year $512.54M.
- 2025-09-30: Other Commitment, to be Paid, Remainder of Fiscal Year $283.50M.
- 2025-06-30: Other Commitment, to be Paid, Remainder of Fiscal Year $326.10M.
| Period end | Other Commitment, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $394.16M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $512.54M 10-Q · filed 2026-05-06 |
| 2025-09-30 | $283.50M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $326.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $265.22M 10-Q · filed 2025-05-07 |
| 2024-09-30 | $144.76M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $147.07M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $210.88M 10-Q · filed 2024-05-08 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |